Your Complete Guide to Global Clinical Research and GCP Compliance
Common Deficiencies in Statistical Analysis Plan (SAP) & DMC Charter Highlighted in FDA, EMA and MHRA Inspections Understanding Common Deficiencies in Statistical Analysis Plan (SAP) & DMC Charter Highlighted in FDA, EMA and MHRA Inspections In the realm of clinical trials, statistical analysis plans (SAP) and Data Monitoring Committees (DMC) charters serve as critical documents…
Case Studies: Systemic Non-Compliance That Led to Critical Findings Case Studies: Systemic Non-Compliance That Led to Critical Findings In the realm of clinical trials, compliance with protocols and regulatory requirements is paramount. Non-compliance can lead not only to operational inefficiencies but also to critical findings that compromise the integrity of clinical research. This comprehensive guide…
Read More “Case Studies: Systemic Non-Compliance That Led to Critical Findings” »
Using Audit, Monitoring and Deviation Data to Diagnose Systemic Issues Using Audit, Monitoring and Deviation Data to Diagnose Systemic Issues Introduction to Clinical Trial Compliance Maintaining compliance in clinical trials is a foundational element that affects the integrity of the data collected, patient safety, and overall trial success. Clinical trial compliance primarily refers to adherence…
Read More “Using Audit, Monitoring and Deviation Data to Diagnose Systemic Issues” »
Aligning Device & Diagnostic Transparency With ICH, GCP and Transparency Regulations In the evolving landscape of clinical trials, the need for transparency in device and diagnostic studies has become a focal point for regulatory bodies across the globe. This detailed tutorial aims to guide clinical operations, regulatory affairs, and medical affairs professionals in understanding how…
Read More “Aligning Device & Diagnostic Transparency With ICH, GCP and Transparency Regulations” »
Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials Introduction to Clinical Trial Transparency In the realm of clinical research, particularly involving high-profile and late-phase trials, transparency is paramount. This holds true for medical devices and diagnostics, where the expectations of regulatory agencies such…
Read More “Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials” »
Statistical Analysis Plan (SAP) & DMC Charter in Practice: Step-by-Step Guide for Sponsors, CROs and Sites Statistical Analysis Plan (SAP) & DMC Charter in Practice: Step-by-Step Guide for Sponsors, CROs and Sites The development and execution of a clinical trial involves multiple critical components, among which the Statistical Analysis Plan (SAP) and the Data Monitoring…
How to Escalate Systemic Non-Compliance to Senior Quality Governance In clinical research, maintaining compliance with regulations and standards established by authorities such as the FDA, EMA, and MHRA is crucial for the integrity and success of clinical trials. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals on…
Read More “How to Escalate Systemic Non-Compliance to Senior Quality Governance” »
Isolated Deviations: When Targeted Corrections Are Enough Introduction to Protocol Deviations in Clinical Trials In clinical trials, maintaining compliance with regulatory standards is critical. Protocol deviations, which occur when the trial’s procedures differ from what was originally established, can jeopardize the integrity of clinical trial outcomes. Understanding the nuances of protocol deviations—particularly between isolated and…
Read More “Isolated Deviations: When Targeted Corrections Are Enough” »
Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs Clinical trials are critical in the development and approval of medical devices and diagnostics. Ensuring transparency in these trials is not only a regulatory requirement but also vital to maintain public…
Read More “Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs” »
Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings Transparency in clinical trials is crucial, especially concerning devices and diagnostics. It not only ensures compliance with regulatory standards but also fosters trust among stakeholders, including patients, researchers, and regulatory authorities….
Read More “Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.